The antibiotic therapy of salmonellosis has changed during the last decade, due to the development of resistance to classical drugs and also to increased knowledge in the conditions of in vitro and in vivo efficacy of new compounds. These new informations led to clinical studies of efficacy and tolerance of fluoroquinolones in the treatment of acute diarrhea or chronic carriage due to Salmonella, or against typhoid fever. These drugs appeared very efficacious and able to significantly shorten the duration of treatment. However, two potential pitfalls have to be kept in mind deserving additional informations: selection of resistant mutants and increased risk of persistent carriage.